RESUMEN
AIM: This review aims to summarize the epidemiology, etiology, pathogenesis, clinical manifestations, and current diagnostic and therapeutic approaches for mucormycosis. The goal is to improve understanding of mucormycosis and promote early diagnosis and treatment to reduce mortality. METHODS: A comprehensive literature review was conducted, focusing on recent studies and data on mucormycosis. The review includes an analysis of the disease's epidemiology, etiology, and pathogenesis, as well as current diagnostic techniques and therapeutic strategies. RESULTS: Mucormycosis is increasingly prevalent due to the growing immunocompromised population, the COVID-19 pandemic, and advances in detection methods. The pathogenesis is closely associated with the host immune status, serum-free iron levels, and the virulence of Mucorales. However, the absence of typical clinical manifestations complicates diagnosis, leading to missed or delayed diagnoses and higher mortality. CONCLUSION: An enhanced understanding of the epidemiology, pathogenesis, and clinical presentation of mucormycosis, along with the adoption of improved diagnostic and therapeutic approaches, is essential for reducing mortality rates associated with this opportunistic fungal infection. Early diagnosis and prompt treatment are critical to improving patient outcomes.
The incidence of mucormycosis has increased following the COVID-19 pandemic.The presence of the halo sign and reverse halo sign may indicate the onset of pulmonary mucormycosis.Early implementation of molecular diagnostic methods, such as mNGS and qPCR, may improve the early diagnosis rate of mucormycosis.Isavuconazole and posaconazole can also be considered as first-line treatments for the initial management of mucormycosis.
Asunto(s)
Antifúngicos , COVID-19 , Mucormicosis , Mucormicosis/epidemiología , Mucormicosis/terapia , Mucormicosis/diagnóstico , Humanos , COVID-19/epidemiología , COVID-19/terapia , Antifúngicos/uso terapéutico , Mucorales/patogenicidad , Mucorales/aislamiento & purificación , Huésped Inmunocomprometido , SARS-CoV-2 , Infecciones Oportunistas/epidemiología , Infecciones Oportunistas/microbiología , Infecciones Oportunistas/diagnóstico , Infecciones Oportunistas/terapiaRESUMEN
BACKGROUND: Mucorales, as one major order of Zygomycetes fungi, can infect human beings and cause serious consequence. We have noticed the pathogenicity of Mucorales is closely related to energy metabolism, while mitochondria play the role of energy factories in almost all biological activities. METHODS: Virulence of M irregularis, M hiemalis, L corymbifera and R arrhizus were verified in Galleria mellonella larvae, as well as mitochondrial gene copies analysed with RT-qPCR. Mitogenomes of the four Mucorales species were sequenced based on illumina NovaSeq technology to study their characteristic features and functional regions. RESULTS: Variant virulence of M irregularis, M hiemalis, L corymbifera and R arrhizu were verified by clinical retrospective data and our G mellonella infection models, also copies of mitochondrial genes indicated the significant associations with pathogenicity. A total of 274.18 clean reads were generated to be assembled; the complete mitogenomes of the four Mucorales species were obtained with totally different length. After the genomes annotated and compared, M irregularis was found more similar with M hiemalis than those of L corymbifera and R arrhizus, especially the small (rrns) and large (rrnl) subunits of mitochondrial ribosomal RNA (rRNA) genes. The GC content, ncRNAs and the distribution of the SNPs and InDels were also compared, and the GC content rate of fungi seems to be related to the fungal thermal adaptability. In addition, linear mitogenomes of these four Mucorales showed diverse arrangements of orf genes and directionality of some conserved gene elements. CONCLUSION: This study uncovered the pathogenicity variances among the four Mucorales species and the relationship between their mitogenomic features and clinical pathogenicity. Further studies like spatial structure of mitochondrial genomes and the comprehensive analysis of transcription regulation are needed.
Asunto(s)
Genoma Fúngico , Genoma Mitocondrial , Mucorales , Humanos , Mucorales/genética , Mucorales/patogenicidad , Mucormicosis , Virulencia/genéticaAsunto(s)
COVID-19/complicaciones , Hierro/sangre , Mucorales/patogenicidad , Mucormicosis/terapia , Probióticos/uso terapéutico , Animales , COVID-19/sangre , COVID-19/inmunología , COVID-19/virología , Interacciones Huésped-Patógeno , Humanos , Quelantes del Hierro/uso terapéutico , Mucorales/inmunología , Mucorales/metabolismo , Mucormicosis/sangre , Mucormicosis/inmunología , Mucormicosis/microbiología , Probióticos/efectos adversos , SARS-CoV-2/inmunología , SARS-CoV-2/patogenicidad , VirulenciaAsunto(s)
Antifúngicos/uso terapéutico , COVID-19/complicaciones , Infecciones Fúngicas del Sistema Nervioso Central/tratamiento farmacológico , Infecciones Fúngicas del Ojo/tratamiento farmacológico , Mucorales/efectos de los fármacos , Mucormicosis/tratamiento farmacológico , Enfermedades Nasales/tratamiento farmacológico , Enfermedades Orbitales/tratamiento farmacológico , Antifúngicos/efectos adversos , COVID-19/inmunología , COVID-19/virología , Infecciones Fúngicas del Sistema Nervioso Central/inmunología , Infecciones Fúngicas del Sistema Nervioso Central/microbiología , Infecciones Fúngicas del Ojo/inmunología , Infecciones Fúngicas del Ojo/microbiología , Interacciones Huésped-Patógeno , Humanos , Mucorales/inmunología , Mucorales/patogenicidad , Mucormicosis/inmunología , Mucormicosis/microbiología , Enfermedades Nasales/inmunología , Enfermedades Nasales/microbiología , Enfermedades Orbitales/inmunología , Enfermedades Orbitales/microbiología , Factores de Riesgo , SARS-CoV-2/inmunología , SARS-CoV-2/patogenicidad , Resultado del TratamientoRESUMEN
COVID-19 is a global health crisis that continues to pose new challenges all around the world. Amidst the growing pandemic, a spike in the number of mucormycosis cases in India and Pakistan has been reported in COVID-19 patients and in those who have recovered from COVID-19. This increase in cases may be related to the overuse of steroids and zinc, the use of industrial oxygen, unsterilized medical equipment, frequent intubation, a weakened immune system, and pre-existing comorbidities such as diabetes. As a result, it is critical to take steps to handle the current increase in mucormycosis cases. Therefore, this article aims to highlight the existence of mucormycosis amidst the COVID-19 pandemic in India and Pakistan, focusing on possible causes and implications, and suggests important plans of action to be taken during this pandemic.
Asunto(s)
COVID-19/epidemiología , Coinfección/epidemiología , Mucorales/patogenicidad , Mucormicosis/epidemiología , Antifúngicos/uso terapéutico , Coinfección/microbiología , Coinfección/virología , Comorbilidad , Humanos , Huésped Inmunocomprometido , India/epidemiología , Mucormicosis/tratamiento farmacológico , Mucormicosis/etiología , Mucormicosis/virología , Pakistán/epidemiología , Factores de RiesgoRESUMEN
Mucormycosis is a deadly infection which is caused by fungi of the order Mucorales including species belonging to the genus Rhizopus, Mucor, Mycocladus, Rhizomucor, Cunninghamella, and Apophysomyces. Despite antifungal therapy and surgical procedures, the mortality rate of this disease is about 90-100% which is exceptionally high. The hypersensitivity of patients with raised available serum iron indicates that the Mucorales are able to use host iron as a critical factor of virulence. This is because iron happens to be a crucial element playing its role in the growth of cells and development. In this review, we have described Lactoferrin (Lf) as a potential iron-chelator. Lf is a naturally occurring glycoprotein which is expressed in most of the biological fluids. Moreover, Lf possesses exclusive anti-inflammatory effects along with several anti-fungal effects that could prove to be helpful to the pathological physiology of inexorable mucormycosis cases. This literature summarises the biological insights into the Lf being considered as a potential fungistatic agent and an immune regulator. The review also proposes that unique potential of Lf as an iron-chelator can be exploited as the adjunct treatment for mucormycosis infection.
Asunto(s)
Antifúngicos/uso terapéutico , Quelantes del Hierro/uso terapéutico , Hierro/metabolismo , Lactoferrina/uso terapéutico , Mucorales/efectos de los fármacos , Mucormicosis/tratamiento farmacológico , Animales , Antifúngicos/efectos adversos , Interacciones Huésped-Patógeno , Humanos , Quelantes del Hierro/efectos adversos , Lactoferrina/efectos adversos , Mucorales/metabolismo , Mucorales/patogenicidad , Mucormicosis/diagnóstico , Mucormicosis/metabolismo , Mucormicosis/microbiología , Valor Predictivo de las Pruebas , Factores de RiesgoRESUMEN
Fungal pneumonia is a dreaded complication encountered after kidney transplantation, complicated by increased mortality and often associated with graft failure. Diagnosis can be challenging because the clinical presentation is non-specific and diagnostic tools have limited sensitivity and specificity in kidney transplant recipients and must be interpreted in the context of the clinical setting. Management is difficult due to the increased risk of dissemination and severity, multiple comorbidities, drug interactions and reduced immunosuppression which should be applied as an important adjunct to therapy. This review will focus on the main causes of fungal pneumonia in kidney transplant recipients including Pneumocystis, Aspergillus, Cryptococcus, mucormycetes and Histoplasma. Epidemiology, clinical presentation, laboratory and radiographic features, specific characteristics will be discussed with an update on diagnostic procedures and treatment.
Asunto(s)
Aspergillus/patogenicidad , Cryptococcus/patogenicidad , Histoplasma/patogenicidad , Trasplante de Riñón/efectos adversos , Enfermedades Pulmonares Fúngicas/diagnóstico , Enfermedades Pulmonares Fúngicas/microbiología , Mucorales/patogenicidad , Pneumocystis/patogenicidad , Neumonía/diagnóstico , Neumonía/microbiología , Antifúngicos/administración & dosificación , Antifúngicos/efectos adversos , Interacciones Farmacológicas , Femenino , Humanos , Huésped Inmunocomprometido , Enfermedades Pulmonares Fúngicas/tratamiento farmacológico , Enfermedades Pulmonares Fúngicas/epidemiología , Masculino , Neumonía/tratamiento farmacológico , Neumonía/epidemiologíaRESUMEN
Mucormycosis is a rare but aggressive fungal disease that mainly affects patients with poorly controlled diabetes mellitus and those who are severely immunocompromised, including patients with hematological malignancies and solid organ transplant recipients. Early recognition of infection is critical for treatment success, followed by prompt initiation of antifungal therapy with lipid formulation amphotericin B. Posaconazole and isavuconazole should be used for stepdown and salvage therapy. Surgical debridement is key for tissue diagnosis and treatment and should be pursued urgently whenever possible. In addition to surgery and antifungal therapy, reverting the underlying risk factor for infection is important for treatment response.
Asunto(s)
Antifúngicos/uso terapéutico , Diabetes Mellitus Tipo 2/complicaciones , Huésped Inmunocomprometido , Mucorales/patogenicidad , Mucormicosis/tratamiento farmacológico , Humanos , Mucorales/aislamiento & purificación , Mucormicosis/diagnóstico , Mucormicosis/epidemiologíaRESUMEN
Members of the ribonuclease III (RNase III) family regulate gene expression by processing double-stranded RNA (dsRNA). This family includes eukaryotic Dicer and Drosha enzymes that generate small dsRNAs in the RNA interference (RNAi) pathway. The fungus Mucor lusitanicus, which causes the deadly infection mucormycosis, has a complex RNAi system encompassing a non-canonical RNAi pathway (NCRIP) that regulates virulence by degrading specific mRNAs. In this pathway, Dicer function is replaced by R3B2, an atypical class I RNase III, and small single-stranded RNAs (ssRNAs) are produced instead of small dsRNA as Dicer-dependent RNAi pathways. Here, we show that R3B2 forms a homodimer that binds to ssRNA and dsRNA molecules, but exclusively cuts ssRNA, in contrast to all known RNase III. The dsRNA cleavage inability stems from its unusual RNase III domain (RIIID) because its replacement by a canonical RIIID allows dsRNA processing. A crystal structure of R3B2 RIIID resembles canonical RIIIDs, despite the low sequence conservation. However, the groove that accommodates dsRNA in canonical RNases III is narrower in the R3B2 homodimer, suggesting that this feature could be responsible for the cleavage specificity for ssRNA. Conservation of this activity in R3B2 proteins from other mucormycosis-causing Mucorales fungi indicates an early evolutionary acquisition.
Asunto(s)
Proteínas Fúngicas/química , Proteínas Fúngicas/metabolismo , Mucor/enzimología , Ribonucleasa III/química , Ribonucleasa III/metabolismo , Evolución Molecular , Proteínas Fúngicas/genética , Modelos Moleculares , Mucorales/enzimología , Mucorales/patogenicidad , Dominios Proteicos , ARN/metabolismo , Ribonucleasa III/genética , VirulenciaRESUMEN
Mucorales are the causal agents for the lethal disease known as mucormycosis. Mortality rates of mucormycosis can reach up to 90%, due to the mucoralean antifungal drug resistance and the lack of effective therapies. A concerning urgency among the medical and scientific community claims to find targets for the development of new treatments. Here, we reviewed different studies describing the role and machinery of a novel non-canonical RNAi pathway (NCRIP) only conserved in Mucorales. Its non-canonical features are the independence of Dicer and Argonaute proteins. Conversely, NCRIP relies on RNA-dependent RNA Polymerases (RdRP) and an atypical ribonuclease III (RNase III). NCRIP regulates the expression of mRNAs by degrading them in a specific manner. Its mechanism binds dsRNA but only cuts ssRNA. NCRIP exhibits a diversity of functional roles. It represses the epimutational pathway and the lack of NCRIP increases the generation of drug resistant strains. NCRIP also regulates the control of retrotransposons expression, playing an essential role in genome stability. Finally, NCRIP regulates the response during phagocytosis, affecting the multifactorial process of virulence. These critical NCRIP roles in virulence and antifungal drug resistance, along with its exclusive presence in Mucorales, mark this pathway as a promising target to fight against mucormycosis.
Asunto(s)
Farmacorresistencia Fúngica , Mucorales/patogenicidad , Interferencia de ARN , Antifúngicos/farmacología , Mucorales/efectos de los fármacos , Mucorales/genética , Estabilidad del ARN , ARN de Hongos/genética , ARN Mensajero/química , Transducción de SeñalRESUMEN
The pathogenesis of life-threatening infections caused by emerging fungal pathogens remains largely unexplored. A new study provides unprecedented evidence for the pivotal role of a new ricin-like protein toxin, named mucoricin, in causing organ necrosis and mortality in Mucorales infections.
Asunto(s)
Mucorales/química , Mucorales/patogenicidad , Micotoxinas , Animales , Humanos , Ratones , Mucormicosis/microbiología , PonzoñasRESUMEN
Mucormycosis is a lethal disease caused by Mucorales, which are emerging as human causes that explain the high mortality for this disease. Consequently, the research community is searching for virulence determinants that could be repurposed as targets to develop new treatments against mucormycosis. Our work explores an RNA interference (RNAi)-based approach to find targets involved in the virulence of Mucorales. A transcriptomewide analysis compared sRNAs and their target mRNAs in two Mucor lusitanicus different pathotypes, virulent and avirulent, generating a list of 75 loci selected by their differential sRNA accumulation in these strains. As a proof of concept and validity, an experimental approach characterized two loci showing opposite behavior, confirming that RNAi activity causes their differential expression in the two pathotypes. We generated deletion mutants for two loci and a knockin-strain overexpressing for one of these loci. Their functional analysis in murine virulence assays identified the gene wex1, a putative DEDDy exonuclease with RNase domains, as an essential factor for virulence. The identification of wex1 showed the potential of our approach to discover virulence factors not only in Mucorales but also in any other fungal model with an active RNAi machinery. More importantly, it adds a new layer to the biological processes controlled by RNAi in M. lusitanicus, confirming that the Dicer-dependent RNAi pathway can silence gene expression to promote virulence.
Asunto(s)
Exonucleasas/genética , Mucorales/genética , Mucorales/patogenicidad , Interferencia de ARN , Regulación Fúngica de la Expresión Génica , Genes Fúngicos , Mutación/genética , ARN de Hongos/genética , ARN de Hongos/metabolismo , Transcriptoma/genética , Virulencia/genéticaRESUMEN
Fungi of the order Mucorales cause mucormycosis, a lethal infection with an incompletely understood pathogenesis. We demonstrate that Mucorales fungi produce a toxin, which plays a central role in virulence. Polyclonal antibodies against this toxin inhibit its ability to damage human cells in vitro and prevent hypovolemic shock, organ necrosis and death in mice with mucormycosis. Inhibition of the toxin in Rhizopus delemar through RNA interference compromises the ability of the fungus to damage host cells and attenuates virulence in mice. This 17 kDa toxin has structural and functional features of the plant toxin ricin, including the ability to inhibit protein synthesis through its N-glycosylase activity, the existence of a motif that mediates vascular leak and a lectin sequence. Antibodies against the toxin inhibit R. delemar- or toxin-mediated vascular permeability in vitro and cross react with ricin. A monoclonal anti-ricin B chain antibody binds to the toxin and also inhibits its ability to cause vascular permeability. Therefore, we propose the name 'mucoricin' for this toxin. Not only is mucoricin important in the pathogenesis of mucormycosis but our data suggest that a ricin-like toxin is produced by organisms beyond the plant and bacterial kingdoms. Importantly, mucoricin should be a promising therapeutic target.
Asunto(s)
Mucorales/patogenicidad , Mucormicosis/patología , Micotoxinas/metabolismo , Ricina/metabolismo , Animales , Antitoxinas/inmunología , Antitoxinas/farmacología , Antitoxinas/uso terapéutico , Apoptosis , Permeabilidad Capilar , Células Cultivadas , Reacciones Cruzadas , Humanos , Hifa/química , Hifa/patogenicidad , Lectinas/metabolismo , Ratones , Mucorales/química , Mucorales/clasificación , Mucorales/genética , Mucormicosis/microbiología , Mucormicosis/prevención & control , Micotoxinas/química , Micotoxinas/genética , Micotoxinas/inmunología , Necrosis , Interferencia de ARN , Rhizopus/química , Rhizopus/genética , Rhizopus/patogenicidad , Proteínas Inactivadoras de Ribosomas/metabolismo , Ricina/química , Ricina/inmunología , Virulencia/efectos de los fármacos , Virulencia/genéticaRESUMEN
BACKGROUND: Mucormycosis is a rare, invasive disease associated with high mortality rates, produced by opportunistic pathogens related to the Mucorales order and characterised by a diverse range of clinical forms; acute rhino-orbital-cerebral and pulmonary symptoms are the most reported ones. OBJECTIVES: To report the experience of mucormycosis observed in a tertiary-care hospital in Mexico for 35 years. METHODS: This was a retrospective, descriptive and observational study on mucormycosis at a tertiary-care hospital in Mexico from January 1985 to December 2019. Demographic and clinical data and mycological and histopathological records were selected. RESULTS: Two hundred fourteen proven cases of mucormycosis for 35 years at a tertiary-care hospital in Mexico were included. Most of the cases were male patients with a median age of 45 years. The two most associated underlying diseases were diabetes mellitus (76.6%) and haematologic malignancy (15.4%). The three primary clinical forms were as follows: rhino-orbito-cerebral (75.9%), cutaneous (8.41%) and pulmonary (7.47%) mucormycosis. The most isolated agents were Rhizopus arrhizus (58.4%) and Lichtheimia corymbifera (12.3%). The overall therapeutic response was 58.5%, and the best response was observed with amphotericin B deoxycholate and surgical debridement. CONCLUSION: Mucormycosis is an emerging disease, and its incidence has increased at our hospital over the years. In this study, the rhino-cerebral clinical type was the most frequent in patients with uncontrolled diabetes; the main aetiological agent was R. arrhizus. Early diagnosis, control of the underlying disease and prompt management may increase the survival rate.
Asunto(s)
Mucormicosis/epidemiología , Mucormicosis/mortalidad , Centros de Atención Terciaria/estadística & datos numéricos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Anfotericina B/uso terapéutico , Antifúngicos/uso terapéutico , Niño , Preescolar , Ácido Desoxicólico/uso terapéutico , Combinación de Medicamentos , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Registros Médicos , México/epidemiología , Persona de Mediana Edad , Mucorales/genética , Mucorales/patogenicidad , Mucormicosis/tratamiento farmacológico , Estudios Retrospectivos , Factores de Tiempo , Adulto JovenRESUMEN
The epidemiology of invasive fungal infections (IFIs) in immunocompromised individuals has changed over the last few decades, partially due to the increased use of antifungal agents to prevent IFIs. Although this strategy has resulted in an overall reduction in IFIs, a subset of patients develop breakthrough IFIs with substantial morbidity and mortality in this population. Here, we review the most significant risk factors for breakthrough IFIs in haematology patients, solid organ transplant recipients, and patients in the intensive care unit, focusing particularly on host factors, and highlight areas that require future investigation.
Asunto(s)
Infecciones Fúngicas Invasoras , Corticoesteroides/efectos adversos , Antifúngicos/uso terapéutico , Aspergillus/aislamiento & purificación , Aspergillus/patogenicidad , Candida/aislamiento & purificación , Candida/patogenicidad , Catéteres Venosos Centrales/efectos adversos , Catéteres Venosos Centrales/microbiología , Equinocandinas/uso terapéutico , Fluconazol/uso terapéutico , Fusarium/aislamiento & purificación , Fusarium/patogenicidad , Predisposición Genética a la Enfermedad , Neoplasias Hematológicas/complicaciones , Humanos , Huésped Inmunocomprometido , Unidades de Cuidados Intensivos , Infecciones Fúngicas Invasoras/diagnóstico , Infecciones Fúngicas Invasoras/tratamiento farmacológico , Infecciones Fúngicas Invasoras/epidemiología , Infecciones Fúngicas Invasoras/prevención & control , Mucorales/aislamiento & purificación , Mucorales/patogenicidad , Micosis/diagnóstico , Micosis/tratamiento farmacológico , Micosis/epidemiología , Micosis/prevención & control , Neutropenia/complicaciones , Infecciones Oportunistas/tratamiento farmacológico , Infecciones Oportunistas/epidemiología , Infecciones Oportunistas/microbiología , Infecciones Oportunistas/prevención & control , Trasplante de Órganos/efectos adversos , Penicillium/aislamiento & purificación , Penicillium/patogenicidad , Factores de Riesgo , Triazoles/uso terapéuticoRESUMEN
Trauma-related necrotizing myocutaneous mucormycosis (NMM) has a high morbidity and mortality in victims of combat-related injuries, geometeorological disasters, and severe burns. Inspired by the observation that several recent clusters of NMM have been associated with extreme mechanical forces (e.g., during tornados), we studied the impact of mechanical stress on Mucoralean biology and virulence in a Drosophila melanogaster infection model. In contrast to other experimental procedures to exert mechanical stress, tornadic shear challenge (TSC) by magnetic stirring induced a hypervirulent phenotype in several clinically relevant Mucorales species but not in Aspergillus or Fusarium Whereas fungal growth rates, morphogenesis, and susceptibility to noxious environments or phagocytes were not altered by TSC, soluble factors released in the supernatant of shear-challenged R. arrhizus spores rendered static spores hypervirulent. Consistent with a rapid decay of TSC-induced hypervirulence, minimal transcriptional changes were revealed by comparative RNA sequencing analysis of static and shear-challenged Rhizopus arrhizus However, inhibition of the calcineurin/heat shock protein 90 (hsp90) stress response circuitry by cyclosporine and tanespimycin abrogated the increased pathogenicity of R. arrhizus spores following TSC. Similarly, calcineurin loss-of-function mutants of Mucor circinelloides displayed no increased virulence capacity in flies after undergoing TSC. Collectively, these results establish that TSC induces hypervirulence specifically in Mucorales and point out the calcineurin/hsp90 pathway as a key orchestrator of this phenotype. Our findings invite future studies of topical calcineurin inhibitor treatment of wounds as an adjunct mitigation strategy for NMM following high-energy trauma.IMPORTANCE Given the limited efficacy of current medical treatments in trauma-related necrotizing mucormycosis, there is a dire need to better understand the Mucoralean pathophysiology in order to develop novel strategies to counteract fungal tissue invasion following severe trauma. Here, we describe that tornadic shear stress challenge transiently induces a hypervirulent phenotype in various pathogenic Mucorales species but not in other molds known to cause wound infections. Pharmacological and genetic inhibition of calcineurin signaling abrogated hypervirulence in shear stress-challenged Mucorales, encouraging further evaluation of (topical) calcineurin inhibitors to improve therapeutic outcomes of NMM after combat-related blast injuries or violent storms.
Asunto(s)
Calcineurina/metabolismo , Mucorales/patogenicidad , Estrés Mecánico , Células A549 , Animales , Drosophila melanogaster , Femenino , Fusarium/genética , Fusarium/patogenicidad , Humanos , Mucorales/genética , Mucormicosis/tratamiento farmacológico , Mucormicosis/microbiología , Fenotipo , Rhizopus oryzae/genética , Rhizopus oryzae/patogenicidad , Esporas Fúngicas/genética , Esporas Fúngicas/patogenicidad , VirulenciaRESUMEN
Epimutations in fungal pathogens are emerging as novel phenomena that could explain the fast-developing resistance to antifungal drugs and other stresses. These epimutations are generated by RNA interference (RNAi) mechanisms that transiently silence specific genes to overcome stressful stimuli. The early-diverging fungus Mucor circinelloides exercises a fine control over two interacting RNAi pathways to produce epimutants: the canonical RNAi pathway and a new RNAi degradative pathway. The latter is considered a non-canonical RNAi pathway (NCRIP) because it relies on RNA-dependent RNA polymerases (RdRPs) and a novel ribonuclease III-like named R3B2 to degrade target transcripts. Here in this work, we uncovered the role of NCRIP in regulating virulence processes and transposon movements through key components of the pathway, RdRP1 and R3B2. Mutants in these genes are unable to launch a proper virulence response to macrophage phagocytosis, resulting in a decreased virulence potential. The transcriptomic profile of rdrp1Δ and r3b2Δ mutants revealed a pre-exposure adaptation to the stressful phagosomal environment even when the strains are not confronted by macrophages. These results suggest that NCRIP represses key targets during regular growth and releases its control when a stressful environment challenges the fungus. NCRIP interacts with the RNAi canonical core to protect genome stability by controlling the expression of centromeric retrotransposable elements. In the absence of NCRIP, these retrotransposons are robustly repressed by the canonical RNAi machinery; thus, supporting the antagonistic role of NCRIP in containing the epimutational pathway. Both interacting RNAi pathways might be essential to govern host-pathogen interactions through transient adaptations, contributing to the unique traits of the emerging infection mucormycosis.
Asunto(s)
Mucorales/genética , Mucormicosis/genética , Interferencia de ARN , Ribonucleasa III/genética , Antifúngicos/farmacología , Farmacorresistencia Fúngica/genética , Epigénesis Genética/genética , Proteínas Fúngicas/genética , Regulación Fúngica de la Expresión Génica/genética , Inestabilidad Genómica/efectos de los fármacos , Interacciones Huésped-Patógeno/genética , Mucorales/patogenicidad , Mucormicosis/microbiología , Mutación/genética , ARN Mensajero/genética , Transducción de Señal/efectos de los fármacos , Virulencia/genéticaRESUMEN
BACKGROUND: Invasive mould infections (IMIs) are very rare in patients with lymphoid malignancies. However, IMIs, mostly due to Aspergillus species, have been increasingly reported in such patients receiving ibrutinib (IBR). There is paucity of information regarding non-Aspergillus invasive mould infections (NAIMIs) in this setting, OBJECTIVES: To review our recent experience and the published literature on the topic. PATIENTS/METHODS: We present a case of invasive sinusitis caused by Fusarium in a patient with refractory chronic lymphocytic leukaemia (CLL) who was treated with IBR and review the 12 published cases of NAIMIs during IBR. RESULTS: Nearly all cases of NAIMIs in the setting of IBR use were encountered in patients with CLL. Mixed fungal infections, brain involvement and late-onset infections were common. CONCLUSIONS: Although rare, NAIMIs should be considered in patients who receive IBR.